These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6139625)

  • 1. Phage therapy.
    Lancet; 1983 Dec; 2(8362):1287-8. PubMed ID: 6139625
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bacteriophages and phage therapy in pediatric practice].
    Samsygina GA; Boni EG
    Pediatriia; 1984 Apr; (4):67-70. PubMed ID: 6233534
    [No Abstract]   [Full Text] [Related]  

  • 3. [Phagotherapy: a nightmare for bacteria, a dream for physicians?].
    Debarbieux L; Saussereau E; Maura D
    Biol Aujourdhui; 2013; 207(3):181-90. PubMed ID: 24330971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on bacteriophage penetration in patients subjected to phage therapy.
    Weber-Dabrowska B; Dabrowski M; Slopek S
    Arch Immunol Ther Exp (Warsz); 1987; 35(5):563-8. PubMed ID: 3332066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of bacteriophage treatment of suppurative bacterial infections. III. Detailed evaluation of the results obtained in further 150 cases.
    Slopek S; Durlakowa I; Weber-Dabrowska B; Dabrowski M; Kucharewicz-Krukowska A
    Arch Immunol Ther Exp (Warsz); 1984; 32(3):317-35. PubMed ID: 6395825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phage therapy: past history and future prospects.
    Carlton RM
    Arch Immunol Ther Exp (Warsz); 1999; 47(5):267-74. PubMed ID: 10604231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental phage therapy in the beginning of the 21st century].
    Debarbieux L
    Med Mal Infect; 2008 Aug; 38(8):421-5. PubMed ID: 18692973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New perspectives of the phage therapy].
    Eyer L; Pantůcek R; Růzicková V; Doskar J
    Klin Mikrobiol Infekc Lek; 2007 Dec; 13(6):231-5. PubMed ID: 18320502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Some immunological changes in children with bacterial infections treated with bacteriophages].
    Pagava KI; Metskhvarishvili GD; Gachechiladze KK; Korinteli IA; Khoĭle N; Dzuliashvili MG
    Georgian Med News; 2012 Nov; (212):64-9. PubMed ID: 23221141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterisation of two novel coliphages with high potential to control antibiotic-resistant pathogenic Escherichia coli (EHEC and EPEC).
    Viscardi M; Perugini AG; Auriemma C; Capuano F; Morabito S; Kim KP; Loessner MJ; Iovane G
    Int J Antimicrob Agents; 2008 Feb; 31(2):152-7. PubMed ID: 18082374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of bacteriophage treatment of suppurative bacterial infections. II. Detailed evaluation of the results.
    Slopek S; Durlakowa I; Weber-Dabrowska B; Kucharewicz-Krukowska A; Dabrowski M; Bisikiewicz R
    Arch Immunol Ther Exp (Warsz); 1983; 31(3):293-327. PubMed ID: 6651485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteriophages as an efficient therapy for antibiotic-resistant septicemia in man.
    Weber-Dabrowska B; Mulczyk M; Górski A
    Transplant Proc; 2003 Jun; 35(4):1385-6. PubMed ID: 12826166
    [No Abstract]   [Full Text] [Related]  

  • 13. [Enteric phage-bacterium systems. Incidence of lysogeny and enteric phages in enterobacterial infections. Preliminary note].
    Ciucă M; Rusu V; Baron O; Maghearu S
    Arch Roum Pathol Exp Microbiol; 1964 Sep; 23(3):587-92. PubMed ID: 5318788
    [No Abstract]   [Full Text] [Related]  

  • 14. Phage therapy gets revitalized.
    Reardon S
    Nature; 2014 Jun; 510(7503):15-6. PubMed ID: 24899282
    [No Abstract]   [Full Text] [Related]  

  • 15. T-even-related bacteriophages as candidates for treatment of Escherichia coli urinary tract infections.
    Nishikawa H; Yasuda M; Uchiyama J; Rashel M; Maeda Y; Takemura I; Sugihara S; Ujihara T; Shimizu Y; Shuin T; Matsuzaki S
    Arch Virol; 2008; 153(3):507-15. PubMed ID: 18188500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of bacteriophage treatment of suppurative bacterial infections. IV. Evaluation of the results obtained in 370 cases.
    Slopek S; Kucharewicz-Krukowska A; Weber-Dabrowska B; Dabrowski M
    Arch Immunol Ther Exp (Warsz); 1985; 33(2):219-40. PubMed ID: 2935115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriophage therapy: an alternative to conventional antibiotics.
    Mathur MD; Vidhani S; Mehndiratta PL
    J Assoc Physicians India; 2003 Jun; 51():593-6. PubMed ID: 15266928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy.
    Chibani-Chennoufi S; Sidoti J; Bruttin A; Kutter E; Sarker S; Brüssow H
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2558-69. PubMed ID: 15215109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phage therapy in the fields of veterinary medicine: an overview].
    Völkel I; Czerny CP
    Berl Munch Tierarztl Wochenschr; 2011; 124(7-8):303-12. PubMed ID: 21848038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New infections by bacteria of low pathogenicity. Gram negative bacteriemia, sepsis caused by Bacillus subtilis and spirillas in chemo- and immunotherapy].
    Gsell O
    Dtsch Med Wochenschr; 1972 Mar; 97(9):315-21 passim. PubMed ID: 4621824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.